[1] 徐川, 施海彬, 刘圣, 等. 肝门部胆管癌致梗阻性黄疸介入引流治疗的预后分析[J]. 介入放射学杂志, 2012,21(9):752-755. DOI: 10.3969/j.issn.1008-794X.2012.09.012.
[2] Zhu J, Feng H, Zhang D, et al. Percutaneous transhepatic cholangiography and drainage and endoscopic retrograde cholangiopancreatograph for hilar cholangiocarcinoma: which one is preferred? [J]. Rev Esp Enferm Dig, 2020, 112(12):893-897. DOI: 10.17235/reed.2020.6937/2020.
[3] Cao J, Wang Z, Cai H, et al. Effect of PTCD-based biliary stent placement combined with 125I particle intracavitary irradiation in treating pancreatic head cancer[J]. J BUON, 2020,25(2):1056-1062.
[4] Lee JG. The role of ERCP in pancreaticobiliary malignancies[M]. ERCP, 2020.
[5] Moss AC, Morris E, Mac MP. Palliative biliary stents for obstructing pancreatic carcinoma[J]. Cochrane Database Syst Rev, 2006(1):D4200. DOI: 10.1002/14651858.CD004200.pub4.
[6] 邓毅磊,周梦豪,赵龙栓. 经皮肝穿刺胆道外引流术和内外引流术治疗恶性梗阻性黄疸的疗效[J]. 中华肝胆外科杂志,2020,26(3):203-207. DOI:10.3760/cma.j.issn.1007-8118. 2020.03.011.
[7] Dang YZ, Huang SG, Lu WL, et al. Curative effect of stereotactic body radiotherapy on hepatic hilar carcinoma[J]. Mol Clin Oncol, 2014,2(6):1135-1138. DOI: 10.3892/mco.2014.395.
[8] 陈聪英. 恶性梗阻性黄疸PTCD治疗后患者带管出院的导管维护状况及影响因素分析[J]. 国际医药卫生导报, 2021, 27(2):269-272. DOI: 10.3760/cma.j.issn.1007-1245. 2021.02.030.
[9] O'Brien S, Bhutiani N, Egger M E, et al. Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma[J]. Surg Endosc, 2020,34(3):1186-1190. DOI: 10.1007/s00464-019-06871-2.
[10] Bao G, Liu H, Ma Y, et al. The clinical efficacy and safety of different biliary drainages in malignant obstructive jaundice treatment[J]. Am J Transl Res, 2021,13(6):7400-7405.
[11] Moole H, Bechtold M, Puli S R. Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review[J]. World J Surg Oncol, 2016,14(1):182. DOI: 10.1186/s12957-016- 0933-2.
[12] Wu J, Song L, Zhang Y, et al. Efficacy of percutaneous transhepatic cholangiodrainage (PTCD) in patients with unresectable pancreatic cancer [J]. Tumour Biol, 2014,35(3):2753-2757. DOI: 10.1007/s13277-013-1363-1.
[13] Zhang G Y, Li W T, Peng W J, et al. Clinical outcomes and prediction of survival following percutaneous biliary drainage for malignant obstructive jaundice[J]. Oncol Lett, 2014, 7(4): 1185-1190. DOI: 10.3892/ol.2014.1860.
[14] Qi S, Yan H. Effect of percutaneous transhepatic cholangial drainag + radiofrequency ablation combined with biliary stent implantation on the liver function of patients with cholangiocarcinoma complicated with malignant obstructive jaundice[J]. Am J Transl Res, 2021,13(3):1817-1824.
[15] Yu H, Yuanyuan S, Guo Z, et al. Multifactorial analysis of biliary infection after percutaneous transhepatic biliary drainage treatment of malignant biliary obstruction[J]. J Cancer Res Ther, 2018,14(7):1503-1508. DOI: 10.4103/jcrt.JCRT_256_18.
[16] 谢兴武, 唐先志, 吴鹏, 等. 经皮肝穿刺胆道引流术后胆道感染的主要病原菌类型及药敏试验分析[J/CD]. 中华介入放射学电子杂志, 2018, 6(4):306-310. DOI: 10.3877/cma.j.issn.2095-5782.2018.04.006.
[17] 范小斌, 徐明洲, 贾亚鹏, 等. 恶性梗阻性黄疸PTCD术后胆道感染危险因素及sCD14-ST诊断价值[J]. 中华医院感染学杂志, 2021,31(2):233-237. DOI: 10.11816/cn.ni. 2021- 201762.
[18] 朱飚, 傅建, 朱翔宇, 等. 恶性梗阻性黄疸患者PTCD术后胆道感染病原学与影响因素[J]. 中华医院感染学杂志, 2020, 30(23):3644-3648. DOI: 10.3892/ol.2014.1860.
[19] 彭波, 黄明, 赵玲, 等. 恶性梗阻性黄疸患者PTCD术后胆道感染的临床分析[J]. 昆明医科大学学报, 2013,34(4):89-93. DOI: 10.3969/j.issn.1003-4706.2013.04.024.
[20] 滕春雨. 恶性梗阻性黄疸患者经皮穿刺肝胆管引流术后胆管感染的临床分析及预防研究[J]. 医学综述, 2015,21(11):2107-2109. DOI: 10.3969/j.issn.1006-2084.2015.11.074.
[21] 牛洪涛, 翟仁友, 王剑锋, 等. 恶性梗阻性黄疸患者经皮肝穿胆道引流术后胆道感染危险因素的探讨[J]. 中华放射学杂志, 2011(10):964-968. DOI: 10.3760/cma.j.issn.1005- 1201.2011.10.017.
[22] 黄可, 关文华, 韩焱, 等. 恶性梗阻性黄疸介入治疗术后并发胆道感染的相关因素分析[J]. 河南科技大学学报(医学版), 2014,32(3):177-179. DOI: 10.3969/j.issn.1672- 688X.2014.03.007.
[23] Born P, Rösch T, Triptrap A, et al. Long-term results of percutaneous transhepatic biliary drainage for benign and malignant bile duct strictures[J]. Scand J Gastroenterol, 1998,33(5):544-549. DOI: 10.1080/00365529850172142.
[24] Popat B, Thakkar D, Deshmukh H, et al. Percutaneous transhepatic biliary drainage in the management of post-surgical biliary leaks[J]. Indian J Surg, 2017,79(1):24-28. DOI: 10.1007/s12262-015-1418-1.
[25] Ozden I, Tekant Y, Bilge O, et al. Endoscopic and radiologic interventions as the leading causes of severe cholangitis in a tertiary referral center[J]. Am J Surg, 2005,189(6):702-706. DOI: 10.1016/j.amjsurg.2005.03.010.
[26] Sheen-Chen SM, Hung KS, Ho HT, et al. Effect of glutamine and bile acid on hepatocyte apoptosis after bile duct ligation in the rat[J]. World J Surg, 2004, 28(5):457-460. DOI: 10.1007/s00268-004-7189-7.
[27] Sharma A, Lokeshwar N. Febrile neutropenia in haematological malignancies[J]. J Postgrad Med, 2005,51 Suppl 1: S42-S48. DOI: 10.1093/ofid/ofac079.
[28] Yu H, Guo Z, Xing W, et al. Bile culture and susceptibility testing of malignant biliary obstruction via PTBD[J]. Cardiovasc Intervent Radiol, 2012,35(5):1136-1144. DOI: 10.1007/s00270-011-0263-2.
[29] Bae WK, Moon YS, Kim JH, et al. Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection[J]. Korean J Gastroenterol, 2008, 51(4): 248-254.
[30] Rösch T, Triptrap A, Born P, et al. Bacteriobilia in percutaneous transhepatic biliary drainage: occurrence over time and clinical sequelae. A prospective observational study[J]. Scand J Gastroenterol, 2003,38(11):1162-1168. DOI: 10.1080/00365520310003549.
[31] Madhusudhan KS, Jineesh V, Keshava SN. Indian college of radiology and imaging evidence-based guidelines for percutaneous image-guided biliary procedures[J]. Indian J Radiol Imaging, 2021,31(2): 421-440. DOI: 10.1055/s-0041-1734222.
|